Efficacy of vinorelbine, epirubicin and prednisone combination regimen in pretreated elderly patients with aggressive non-Hodgkin's lymphoma

Haematologica

Volumn 86, Issue 3, 2001, Pages 287-290

  Zinzani, P L ^a   Tani, M ^a   Stefoni, V ^a   Albertini, P ^a   Bendandi, M ^a   Gherlinzoni, F ^a   Alinari, L ^a   Vigna, E ^a   Tura, S ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Elderly aggressive NHL; Pretreated patients; Vinorelbine and epirubicin

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MITOXANTRONE; NAVELBINE; PREDNISONE; VINCRISTINE;

AGED; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HAIR LOSS; HUMAN; MALE; NEUROTOXICITY; NEUTROPENIA; NONHODGKIN LYMPHOMA; PHASE 2 CLINICAL TRIAL; RELAPSE; REMISSION; THROMBOCYTOPENIA;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; EPIRUBICIN; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; PREDNISONE; THERAPEUTIC EQUIVALENCY; TREATMENT OUTCOME; VINBLASTINE;

EID: 0035070441     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Non-Hodgkin's lymphoma time trends: United States and international data
2. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma
3. A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavorable non-Hodgkin's lymphoma
4. A combination of mitoxantrone, etoposide and prednisone in elderly patients with non-Hodgkin's lymphoma
5. Low-dose ACOP-B and VABE: Weekly chemotherapy for elderly patients with advanced-stage diffuse large-cell lymphoma
6. In search of an optimal regimen for elderly patients with advanced-stage diffuse large-cell lymphoma: Results of a phase II study of P/DOCE chemotherapy
7. A phase II trial of a chemotherapy combination in elderly patients with aggressive lymphoma
8. Non-Hodgkin's lymphomas in the elderly: Prospective studies with specifically devised chemotherapy regimens in 66 patients
9. P-VABEC: A prospective study of a new weekly chemotherapy regimen for elderly aggressive non-Hodgkin's lymphoma
10. Elderly patients with aggressive non-Hodgkin's lymphoma: Disease presentation, response to treatment, and survival-a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years
11. VNCOP-B regimen in the treatment of high-grade non-Hodgkin's lymphoma in the elderly Haematologica
12. Elderly aggressive-histology non-Hodgkin's lymphoma: First-line VNCOP-B regimen experience on 350 patients
13. CHOP is the standard regimen in patients ≥70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: Results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group
14. P-VEBEC: A new 8-weekly schedule with or without rG-CSF for elderly patients with aggressive non-Hodgkin's lymphoma (NHL)
15. Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapy
16. Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma
17. The synthesis of navelbine prototype of a new series of vinblastine derivatives
18. Activity of single agent vinorelbine in pretreated non-Hodgkin's lymphoma
19. Current position of vinorelbine in cancer chemotherapy
20. Updated Kiel classification for lymphomas
21. Report of the Committee on Hodgkin's Disease Staging Classification
22. Toxicity and response criteria of the Eastern Cooperative Oncology Group